Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01488318
Title Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.